Drug Approval
What This Page Covers
This page collects the 5 public records POLISCOPE has tagged with “Drug Approval”. Coverage spans bills and news coverage - each decoded into plain English and linked to its primary source. It most often overlaps with Fda, Pancreatic Cancer, and Healthcare.
Active Bills
Recent Activity
Finance Signals
No finance signals found for this topic in the available records yet.
Open the Money page to search by entity, donor, or PAC.
Reported financial relationships and timing signals. This does not prove motive or influence.
Key Actors
- 01Ben Sasseperson2 mentions
- 02Food and Drug Administrationorganization2 mentions
- 03Revolution Medicinesorganization2 mentions
- 04American Cancer Societyorganization2 mentions
- 05Andrew Covelerperson2 mentions
- 06Hawleyperson1 mentions
- 07Padillaperson1 mentions
- 08Gillibrandperson1 mentions
- 09Markus H. Meierperson1 mentions
- 10Homeland Securityorganization1 mentions
Connections Preview
Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.
- Topic to billsPromising Pathway Act 2.0: New Conditional Approval Process for Rare Disease Drugs
- Topic to peopleBen Sasse, Andrew Coveler, Hawley (+3 more)
- Topic to orgsFood and Drug Administration, Revolution Medicines, American Cancer Society (+1 more)
Source Trail
Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.
- Aug 27, 2026NewsFDA approves Rasonque for advanced pancreatic cancer treatment
- Aug 27, 2026NewsFDA approves Rasonque for advanced pancreatic cancer treatment
- May 23, 2024Federal BillPromising Pathway Act 2.0: New Conditional Approval Process for Rare Disease Drugs
- Jan 1, 2018hearing transcriptCongressional Hearing on FDA Approval and Antitrust Issues
Showing 4 of 5 source records.